, Tracking Stock Market Picks
Enter Symbol:
Vertex Pharmaceuticals Incorporated (VRTX) [hlAlert]

up 29.99 %

Vertex Pharmaceuticals Incorporated (VRTX) upgraded to Buy with price target $126 by Argus

Posted on: Monday,  Sep 28, 2015  8:25 AM ET by Argus

Argus rated Buy Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) on 09/28/2015, when the stock price was $102.89. Since
then, Vertex Pharmaceuticals Incorporated has gained 29.99% as of 12/01/2015's recent price of $133.75.
If you would have followed this Argus's recommendation on VRTX, you would have gained 29.99% of your investment in 64 days.

Vertex Pharmaceuticals Inc. discovers, develops and markets small molecule drugs that address major unmet medical needs. The company has eight drug candidates in clinical development to treat viral diseases, inflammation, cancer, autoimmune diseases and neurological disorders. Vertex has created its pipeline using a proprietary information-based approach to drug design that integrates multiple technologies in biology, chemistry and biophysics aimed at increasing the speed and success rate of drug discovery. (PRESS RELEASE)

Argus Research is an independent research firm, and our business is producing, distributing and marketing high-quality investment and economic research. Our recommendations - BUY, HOLD and SELL - reflect the judgment of an analyst about a company's prospects as an investment in terms of value, expected growth and risks. Argus Research does not bring companies public, advise companies on mergers and acquisitions, broker trades, make markets in stocks or manage money. Our independence allows us to make critical judgments about companies that we might not be so free to make were we competing for a firm's underwriting business. Because we're not a broker/dealer, we don't have "inventory" of a stock that we have to move with a tainted recommendation. We have developed a six-point system for analyzing the stocks in our Universe of Coverage. We believe that this system
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/28/2015 8:25 AM Buy
102.89 126.00
as of 12/31/2012
1 Week   
1 Month   
3 Months down  -33.89 %
1 YTD down  -33.89 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/28/2012 9:25 AM Hold
10/4/2012 2:25 PM Buy
59.06 68.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy